Aims/hypothesis
Insulin's rate of entry into skeletal muscle appears to be the rate limiting step for muscle insulin action and is slowed by insulin resistance. Despite its obvious importance, uncertainty remains as to whether the transport of insulin from plasma to muscle interstitium is a passive diffusional process or a saturable transport process regulated by the insulin receptor.
Methods
To address this, here we directly measure the rate of 125I-insulin uptake by rat hindlimb muscle and examine how that is affected by adding unlabeled insulin at high concentrations. We used mono-iodinated ([125I]TyrA14)insulin and short (5 min) exposure times, combined with trichloroacetic acid precipitation, to trace intact bioactive insulin.
Results
Compared to saline, high concentrations of unlabeled insulin delivered either continuously (insulin clamp) or as a single bolus significantly raised plasma 125I-insulin, slowed the movement of 125I-insulin from plasma into liver, spleen, and heart (p<0.05, for each) but increased kidney 125I-insulin uptake. High concentrations of unlabeled insulin delivered either continuously (insulin clamp), or as a single bolus significantly decreased skeletal muscle 125I-insulin clearance (p<0.01 for each). Increasing muscle perfusion by electrical stimulation did not prevent the inhibitory effect of unlabeled insulin on muscle 125I-insulin clearance.
Conclusions/interpretation
This indicates that insulin's trans-endothelial movement within muscle is a saturable process likely involving the insulin receptor. Current findings, together with other recent reports, suggest that trans-endothelial insulin transport may be an important site at which muscle insulin action is modulated in clinical and pathologic settings.